Genetic alterations associated with the evolution and progression of astrocytic brain tumours.

作者: H. Ohgaki , P. Kleihues , B. Schäuble , A. zur Hausen , K. von Ammon

DOI: 10.1007/BF00196514

关键词: Cancer researchCytogeneticsPathologyAstrocytomaGermline mutationTumor suppressor geneNeoplastic transformationAnaplastic astrocytomaBiologyLoss of heterozygosityGlioma

摘要: Diffusely infiltrating low-grade astrocytomas (WHO grade II) have an intrinsic tendency for progression to anaplastic astrocytoma III) and glioblastoma IV). This change is due the sequential acquisition of genetic alterations, several which recently been identified. In astrocytomas, p53 mutations with or without loss heterozygosity on chromosome 17p are principal detectable change. Anaplastic contain at overall incidence 34% and, in addition, 19q frequent homozygous deletion p16 tumor suppressor (MTS-1) gene. The most malignant astrocytic neoplasms, glioblastoma, further shows 10 amplification epidermal growth factor receptor (EGF-R) gene incidences 66% 34%, respectively. type distribution brain tumours not suggestive specific environmental carcinogens operative their aetiology. Analysis 91 families germline reported date show that nervous system account 12% all neoplasms. Of a total 57 reported, 30 were classified histologically these, 73% origin. observation somatic sporadic largely restricted those origin also prevail among CNS neoplasms associated mutation strongly suggests, capable initiating neoplastic transformation astrocytes human system.

参考文章(38)
C. David James, V. Peter Collins, Molecular genetic characterization of CNS tumor oncogenesis. Advances in Cancer Research. ,vol. 58, pp. 121- 142 ,(1992) , 10.1016/S0065-230X(08)60293-6
G Reifenberger, K Ichimura, V P Collins, E E Schmidt, CDKN2 (p16/MTS1) gene deletion or CDK4 amplification occurs in the majority of glioblastomas. Cancer Research. ,vol. 54, pp. 6321- 6324 ,(1994)
Jin Jen, J Wade Harper, Sandra H Bigner, Darell D Bigner, Nickolas Papadopoulos, Sanford Markowitz, James KV Willson, Kenneth W Kinzler, Bert Vogelstein, None, Deletion of p16 and p15 Genes in Brain Tumors Cancer Research. ,vol. 54, pp. 6353- 6358 ,(1994)
Ralf F. Pettersson, A. Jonas Ekstrand, C. David James, V. Peter Collins, V. Peter Collins, Barbara Seliger, Webster K. Cavenee, Genes for Epidermal Growth Factor Receptor, Transforming Growth Factor α, and Epidermal Growth Factor and Their Expression in Human Gliomas in Vivo Cancer Research. ,vol. 51, pp. 2164- 2172 ,(1991)
A. Von Deimling, D. N. Louis, D. N. Louis, B. R. Seizinger, I. Petersen, K. Von Ammon, O. D. Wiestler, Evidence for a Tumor Suppressor Gene on Chromosome 19q Associated with Human Astrocytomas, Oligodendrogliomas, and Mixed Gliomas Cancer Research. ,vol. 52, pp. 4277- 4279 ,(1992)
Gaetano Finocchiaro, Cristiana Giani, Mutation Rate of the CDKN2 Gene in Malignant Gliomas Cancer Research. ,vol. 54, pp. 6338- 6339 ,(1994)
R Godbout, J He, MJ Allalunis-Turner, rd Rs Day, VP Collins, JR Allen, CD James, CDK4 Amplification Is an Alternative Mechanism to p16 Gene Homozygous Deletion in Glioma Cell Lines Cancer Research. ,vol. 54, pp. 5804- 5807 ,(1994)
B. Smith-Sørensen, Eivind Hovig, M. S. Greenblatt, Therese Sorlie, R. Montesano, M. Hollstein, C. C. Harris, K. Rice, R. Fuchs, T. Soussi, Database of p53 gene somatic mutations in human tumors and cell lines. Nucleic Acids Research. ,vol. 22, pp. 3551- 3555 ,(1994)
Richard M. Cawthon, Carolyn A. Pedone, Douglas Brockmeyer, Dan Fults, Micam W. Tullous, p53 mutation and loss of heterozygosity on chromosomes 17 and 10 during human astrocytoma progression. Cancer Research. ,vol. 52, pp. 674- 679 ,(1992)